HAVN Life Sciences's total assets for Q3 2023 were $11.11M, an increase of 244.57% from the previous quarter. HAVLF total liabilities were $540.44K for the fiscal quarter, a -59.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.